Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Infusion pump is a medical device that aids in the delivery of fluids, like nutrients and medications, into a patient’s body in controlled amounts. These pumps are capable of delivering fluids in large or small amounts, and may be used to deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Infusion pumps are in extensive use in various clinical settings including hospitals, nursing homes, and in the home. The different types of infusion pumps are commercially available to be used for a variety of purposes and in a variety of environments.
The demand of the infusion pump is positively affected by demographics such as an aging population and an increasing rate of chronic disease in developed markets and the rise of a middle class in many emerging markets. As per United States National Counselling on Ageing, approximately 80% of older adults have at least one chronic disease, and 77% have at least two. And diseases such as heart disease, cancer, stroke, and diabetes cause almost two-thirds of all deaths each year. Over 33% of cancer survivors have chronic pain and need drugs administered through infusion pumps for rapid relief. Such incidences lead to the growth of the market.
Hospitals fighting the novel coronavirus are not only experiencing shortages of ventilators and personal protective equipment but also of infusion pumps critical for providing medications and fluids to the growing number of hospitalized COVID-19 patients. Severely ill COVID-19 patients may need multiple medications supplied by infusion pumps.
Knowing bigger demand for infusion pumps, FDA recently guidance aimed at spurring access to the devices for patients. The agency will allow infusion pump makers to make any necessary changes to the device to address manufacturing limitations the goal is to give more flexibility to infusion pump companies to address manufacturing limitations and supply shortages related to the public health emergency.
The report analyses the global infusion pump market based product, application, end user and geography.
The various types of infusion pump include implantable infusion pumps, infusion disposable sets, ambulatory infusion pumps, volumetric pumps, syringe pumps. Some are designed mainly for stationary use at a patient’s bedside. Others, called ambulatory infusion pumps, are designed to be portable or wearable. The infusion pump market finds application in chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, haematology etc. The major end users of the market are hospitals, home care settings, ambulatory care settings and academic & research institutes.
The infusion pump market finds application in chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, haematology etc. The increasing prevalence of diabetes is boosting the demand of the infusion pump market. According to the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Thus, the growing need of the smart insulin pumps for diabetes management is likely to boost the demand the of these products.
The major end users of the market are hospitals, home care settings, ambulatory care settings and academic & research institutes.
The infusion pump market is studied for the key regions including North America, Europe, Asia Pacific and Rest of the World. The North America region dominated the global infusion pump market. The large share of North America can be attributed to the high adoption of speciality infusion pump for the treatment of chronic disorders, increasing prevalence of cancer, the presence of many large hospitals. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment
Key players in the global infusion pump market B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter international Inc., Fresenius Kabi, Tandem Diabetes Care, Inc., Jms Co., ltd., Roche Diagnostics , Zyno Medical, ICU Medical, Inc., Smiths Medical , Medtronic Plc, Moog Inc. Terumo corporation, Avanos medical, Inc., Nipro corporation, Insulet corporation, Mindray medical international limited, Micrel medical devices S.A., Ypsomed holding Ag and Teleflex, Inc. among others.
June 2019: The FDA granted Ivenix 510(k) clearance for its Ivenix Infusion System, a large-volume pump and infusion system for the administration of IV drugs. The device was designed to meet agency guidelines on infusion pumps.
August 2017: Smiths Medical received FDA 510k clearance on wireless ambulatory infusion pump. The new system will help the hospitals increase efficiencies, reduce costs and improve patient outcomes.
The various types of infusion pump include implantable infusion pumps, infusion disposable sets, ambulatory infusion pumps, volumetric pumps, syringe pumps. Some are designed mainly for stationary use at a patient’s bedside. Others, called ambulatory infusion pumps, are designed to be portable or wearable. The infusion pump market finds application in chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, haematology etc. The major end users of the market are hospitals, home care settings, ambulatory care settings and academic & research institutes. The infusion pump market is studied for the key regions including North America, Europe, Asia Pacific and Rest of the World.
Key players in the global infusion pump market B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter international Inc., Fresenius Kabi, Tandem Diabetes Care, Inc., Jms Co., ltd., Roche Diagnostics, Zyno Medical, ICU Medical, Inc., Smiths Medical , Medtronic Plc, Moog Inc. Terumo corporation, Avanos medical, Inc., Nipro corporation, Insulet corporation, Mindray medical international limited, Micrel medical devices S.A., Ypsomed holding Ag and Teleflex, Inc. among others.
Why to buy this report:
